Magellan Health, Inc. (MGLN): Price and Financial Metrics
Magellan Health, Inc. (MGLN)
Today's Latest Price: $77.91 USD
Updated Oct 23 6:55pm
Add MGLN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 9 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
MGLN Stock Summary
- Of note is the ratio of Magellan Health Inc's sales and general administrative expense to its total operating expenses; merely 0.34% of US stocks have a lower such ratio.
- With a price/sales ratio of 0.3, Magellan Health Inc has a higher such ratio than just 10.63% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Magellan Health Inc is reporting a growth rate of 143.07%; that's higher than 91.37% of US stocks.
- If you're looking for stocks that are quantitatively similar to Magellan Health Inc, a group of peers worth examining would be IPG, JBGS, UBA, CHCT, and TRNO.
- MGLN's SEC filings can be seen here. And to visit Magellan Health Inc's official web site, go to www.magellanhealth.com.
MGLN Stock Price Chart Interactive Chart >
MGLN Price/Volume Stats
| Current price | $77.91 | 52-week high | $81.04 |
| Prev. close | $77.97 | 52-week low | $30.60 |
| Day low | $77.70 | Volume | 67,600 |
| Day high | $79.13 | Avg. volume | 167,403 |
| 50-day MA | $75.56 | Dividend yield | N/A |
| 200-day MA | $68.20 | Market Cap | 1.97B |
Magellan Health, Inc. (MGLN) Company Bio
Magellan Health provides services to health plans, managed care organizations (MCOs), employers, labor unions, military and governmental agencies, third party administrators, consultants and brokers. Its business is divided into five segments, which include managed healthcare, specialty solutions and pharmacy management. The company was founded in 1969 and is based in Scottsdale, Arizona.
MGLN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $77.91 | $81.43 | 5% |
We started the process of determining a valid price forecast for Magellan Health Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Magellan Health Inc ranked in the 48th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Magellan Health Inc, consider:
- Magellan Health Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 14.55% of tickers in our DCF set.
- Magellan Health Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
- Relative to other stocks in its sector (Healthcare), Magellan Health Inc has a reliance on debt greater than 66.07% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 2% |
| 1% | 3% |
| 2% | 5% |
| 3% | 6% |
| 4% | 7% |
| 5% | 8% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MGLN, try LH, INBP, USPH, MEDP, and AMED.
Loading social stream, please wait...